These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11564549)

  • 1. Investigation of Smith's quinolone killing mechanisms during the PAE of ciprofloxacin on Escherichia coli.
    Wickens HJ; Pinney RJ
    Int J Pharm; 2001 Oct; 227(1-2):149-56. PubMed ID: 11564549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure.
    Wickens HJ; Pinney RJ; Mason DJ; Gant VA
    Antimicrob Agents Chemother; 2000 Mar; 44(3):682-7. PubMed ID: 10681338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
    Zemelman R; Vejar C; Bello H; Domínguez M; González G
    Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Quinolone bactericidal mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anaerobic growth on quinolone lethality with Escherichia coli.
    Malik M; Hussain S; Drlica K
    Antimicrob Agents Chemother; 2007 Jan; 51(1):28-34. PubMed ID: 17043118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the in vivo post-antibiotic effects of ciprofloxacin and rifampicin.
    Meng X; Pei Y; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1995 Dec; 36(6):987-96. PubMed ID: 8821597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli.
    Guan L; Blumenthal RM; Burnham JC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2118-24. PubMed ID: 1280055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of bactericidal activities of quinolones during the post-antibiotic effect induced by rifampicin.
    Meng X; Nightingale CH; Sweeney KR; Quintiliani R
    J Antimicrob Chemother; 1994 Apr; 33(4):721-8. PubMed ID: 8056690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.
    Lewin CS; Howard BM; Smith JT
    J Med Microbiol; 1991 Jan; 34(1):19-22. PubMed ID: 1703579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a pKM101 region which confers a slow growth rate and interferes with susceptibility to quinolone in Escherichia coli AB1157.
    Clerch B; Rivera E; Llagostera M
    J Bacteriol; 1996 Oct; 178(19):5568-72. PubMed ID: 8824598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus.
    Giamarellou-Bourboulis EJ; Sambatakou H; Grecka P; Chryssouli Z; Giamarellou H
    Diagn Microbiol Infect Dis; 1999 Aug; 34(4):301-7. PubMed ID: 10459481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the fractional maximal effect method: comparative interaction studies of ciprofloxacin and protein synthesis inhibitors.
    Li RC; Nix DE; Schentag JJ
    J Chemother; 1996 Feb; 8(1):25-32. PubMed ID: 8835104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal mechanisms of ofloxacin.
    Lewin CS; Smith JT
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():1-8. PubMed ID: 3053574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity.
    Guan L; Burnham JC
    J Antimicrob Chemother; 1992 May; 29(5):529-38. PubMed ID: 1320604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay.
    Tamayo M; Santiso R; Gosalvez J; Bou G; Fernández JL
    BMC Microbiol; 2009 Apr; 9():69. PubMed ID: 19364397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.